Abstract:OBJECTIVE:Adult stem cell senescence and exhaustion are important drivers of organismal age. Restored stem cell self-renewal has revealed novel therapeutic targets for decreasing the incidence of age-associated diseases (AADs) and prolonging the human health span. Transient ectopic expression of the reprogramming factors Oct3/4, Sox2, Klf4 and c-Myc (collectively known as OSKM) in somatic cells can induce partial cellular reprogramming and effectively ameliorate their age-associated hallmarks. However, how this form of rejuvenation is applied to senescent stem cells remains unknown.MATERIALS AND METHODS:The Integrin-α6highCD71high epidermal stem cells (ESCs) with low self-renewal ability were sorted by flow cytometry and then treated by the interrupted reprogramming induced by transient expression of OSKM. The ability of secondary clones' generation and self-proliferation in vitro, as well as stem cell marker p63, were detected to determine their self-renewal ability. Besides, gene and protein of epidermal cell markers were detected to determine whether their cell identities were retained. Finally, DNA methylation age (eAge) and DNA dehydroxymethylase/methyltransferase were analyzed to explore the alternation of their global DNA methylation pattern during this rejuvenation.RESULTS:The partial reprogramming restored the youthful self-renewal and proliferation in senescent ESCs, including larger secondary clone generation, higher expression of stem cell marker p63 and proliferation marker Ki67, and faster proliferation speed, in each case without abolishing epithelial cellular identity. Moreover, the rejuvenation of adult stem cells could be maintained for 2 weeks after reprogramming factor withdrawal, which was more stable than that of differentiated somatic cells. Additionally, we found that partial reprogramming counteracted the acceleration of eAge in senescent epidermal stem cells and DNA methyltransferase 1 (DNMT1) may play a crucial role in this process.CONCLUSIONS:Partial reprogramming has high therapeutic potential for reversing adult stem cell age, providing an advanced way to treat AADs.

Chemically induced reprogramming to reverse cellular aging

Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells

Epigenetic Reprogramming as a Key to Reverse Ageing and Increase Longevity

The long and winding road of reprogramming-induced rejuvenation

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

Systematic Approach Identifies Multiple Transcription Factor Perturbations That Rejuvenate Replicatively Aged Human Skin Fibroblasts

Reprogramming to recover youthful epigenetic information and restore vision

Partial Cellular Reprogramming Stably Restores the Stemness of Senescent Epidermal Stem Cells.

Transcriptomic reprogramming for neuronal age reversal

Genetic and epigenetic alterations in aging and rejuvenation of human

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

Tick tock, tick tock: Mouse culture and tissue aging captured by an epigenetic clock

Reversal of epigenetic aging and immunosenescent trends in humans

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo

Epigenetic rejuvenation by partial reprogramming

Chemical-induced Epigenome Resetting for Regeneration Program Activation in Human Cells

Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases

Multi-Omic Rejuvenation: A New Strategy for Lifespan Extension